Literature DB >> 4454035

Electroimmunoassay of plasma subunits-a and -s in a case of congenital fibrin stabilizing factor deficiency.

T Barbui, G Cartei, T Chisesi, E Dini.   

Abstract

Antigenic material related to the fibrin stabilizing factor (Factor XIII-FSF) has been found in all the examined patients with congenital deficiency, albeit in reduced amount. Recently, Bohn et al. (1973) showed that plasma Factor-XIII is composed by two subunits, A (or a) and S (or b); the former active protein, the latter probably FSF-vinding protein. Using specific anti-S and anti-A antisera the Authors found, in a case of congenital deficiency of factor XIII, absence of subunit A. Subunit S presented abnormal behaviour as demonstrated by means of quantitative immunoelectrophoresis according to Laurell.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4454035

Source DB:  PubMed          Journal:  Thromb Diath Haemorrh        ISSN: 0340-5338


  6 in total

Review 1.  [Blood coagulation factor XIII and fibrin stabilization (author's transl)].

Authors:  H Rasche
Journal:  Klin Wochenschr       Date:  1975-12-15

2.  Genetic polymorphism of the B subunit of human coagulation factor XIII.

Authors:  P G Board
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

3.  Improved coagulation factor XIII B (FXIIIB) phenotyping after neuraminidase treatment of plasma and first description of the FXIIIB 2 phenotype.

Authors:  P Kreckel; P Kühnl
Journal:  Blut       Date:  1982-11

4.  [Longtime therapy of congenital factor XIII deficiency using factor XIII concentrate].

Authors:  R Egbring; K Andrassy; K Havemann; G Fuchs; B Ruf; K Schander; H Trobisch
Journal:  Blut       Date:  1976-12

5.  [Severe factor XIII-deficiency. Studies on subunits and turnover of the fibrin stabilizing factor (author's transl)].

Authors:  R Zimmermann; W Ehlers; F Manz; W Meinrenken; R Egbring; H Gemmeke
Journal:  Blut       Date:  1977-12

6.  Fibrin cross-linking in congenital factor XIII deficiency.

Authors:  F Rodeghiero; T Barbui
Journal:  J Clin Pathol       Date:  1980-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.